Fisher & Paykel Healthcare is loath to provide quantitative guidance for its 2023 financial year as Covid-19 continues to make its consumables revenue unpredictable, but it has produced a model for growth which it hopes will assuage investors’ uncertainty about the future.
That model was revealed
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
